Hayat-Vax The UAE's COVID-19 Vaccine

  • Publish date: Monday، 29 March 2021
Hayat-Vax The UAE's COVID-19 Vaccine
Related articles
UAE Reinforces Wearing of Face Mask Indoors
COVID-19 Protocol Updates for Students and Teachers
Dubai Witnessed a 165-fold Increase in Population in 70 Years

After the UAE and China struck a major vaccine deal on Sunday night, the UAE announced that an Emirati drug maker is already producing Sinophram vaccine. The UAE vaccine will be known as Hayat-Vax, Hayat means 'life' in Arabic.

Officials said production could hit 2 million doses per month as Ras Al Khaimah drug maker Julphar is already rolling off a production line at Julphar's main plant in RAK.

"The new vaccine plant in Kizad will become operational this year and over its phased development will have a production capacity of 200 million doses per annum across three filling lines and five automated packaging lines," the release read.

"The joint venture is already producing Hayat-Vax with its partner, Julphar in UAE with an initial capacity of 2 million doses per month."

RAK’s Julphar and Abu Dhabi's Group 42 said they would further build a dedicated facility in the capital's Kizad freezone.

“Life sciences and vaccine manufacturing in our country is UAE’s contribution towards global efforts to address the Covid-19 pandemic that has affected the whole world." Said Sheikh Abdullah bin Zayed, Minister of Foreign Affairs and International Co-operation.

Image Source: Instagram